Clinical Trials in Arizona

Showing 11201-11220 of 16,770 trials

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

NCT01286987

This is a single-arm, open-label study to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of talazoparib in patients with advanced tumors with DNA-repair pathway deficiencies. There will be 2 parts to the study: a dose escalation phase in which the maximum tolerated dose will be defined, and a dose expansion phase.

Advanced or Recurrent Solid TumorsBreast NeoplasmsOvarian Cancer, Epithelial+4 more

Pfizer113 participantsStarted Jan 2011

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +12 more locations

COMPLETEDPhase 131 miles

A Study in Adult Subjects With Select Advanced Solid Tumors

NCT02583165

To evaluate the safety and tolerability of MEDI1873 in adult subjects with selected advanced solid tumors.

Advanced Solid Tumors

MedImmune LLC40 participantsStarted Nov 2015

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +7 more locations

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

A Study in Adult Subjects With Select Advanced Solid Tumors

Find Trials by Condition in Arizona

Optimal Management of Vasa Previa Study - A Retrospective Study

A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure

A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions

Aspen Spinous Process Fixation System for Use in PLF in Patients With Spondylolisthesis

A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

A Safety Study in Participants With Advanced Solid Tumors

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Telemedicine Outreach for Post Traumatic Stress in CBOCs

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

Detection and Neurological Impact of CerebroVascular Events In Noncardiac Surgery PatIents: A COhort EvaluatioN